Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

This study has been terminated.

( Problems with IRB )

Study NCT00783172 Information provided by Penn State University

First Received: October 30, 2008 Last Updated: August 3, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	October 2011
Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)